Akcea Therapeutics, Inc. Accounts Receivable
Akcea Therapeutics, Inc. had Accounts Receivable of $4.60 million as of 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2019-03-01
- 2018-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $4.60M.
- 2017-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $5.41M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2018-12-31 | $4.60M 10-K · filed 2019-03-01 |
| 2017-12-31 | $5.41M 10-K · filed 2019-03-01 |